• About
  • Masthead
  • License Content
  • Advertise
  • Submit Press Release
  • RSS/Email List
  • 2MM Podcast
  • Write for us
  • Contact Us
2 Minute Medicine
No Result
View All Result

No products in the cart.

SUBSCRIBE
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools+
    • EvidencePulse™
    • HypeCheck™
    • NPI Registry Lookup
    • RVU Search
  • Pharma
  • AI Roundup
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • My account
    • Cart
    • Sign-in
2 Minute Medicine
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools+
    • EvidencePulse™
    • HypeCheck™
    • NPI Registry Lookup
    • RVU Search
  • Pharma
  • AI Roundup
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • My account
    • Cart
    • Sign-in
SUBSCRIBE
2 Minute Medicine
Subscribe
EvidencePulse™ by 2 Minute Medicine 2026 evidence scan 3 reports You asked top stroke trials 2026 Synthesizing medical evidence... Top 2026 stroke trial results: OCEANIC — ischemic stroke: 6.2% vs 8.4% OPTION* — mRS 0–1: 43.6% vs 34.2% ORIENTAL* — mRS 0–2: 58.6% vs 46.6% *Higher sICH in intervention arms Participants randomizedN OCEANIC 12,327 OPTION 570 ORIENTAL 564 Ask about guidelines or landmark trials... ↑ Try EvidencePulse™ Ask the evidence.
Get the signal.
Try it now → Physician-trained medical AI by 2 Minute Medicine
Home All Specialties Emergency

Adenovirus infection associated with hepatitis of unknown cause in children

byNhat Hung (Benjamin) LamandKiera Liblik
August 25, 2022
in Emergency, Gastroenterology, Pediatrics
Reading Time: 2 mins read
Study evaluates family-initiated medication dialogues on rounds
Share on FacebookShare on Twitter

1. Adenovirus was found to be associated with the emerging hepatitis of unknown cause in children in the United Kingdom (UK).

2. Despite a small number of fulminant liver failure requiring transplant, there were no deaths in the study, and patients were discharged home following treatment.

Evidence Rating Level: 2 (Good)

Study Rundown: Acute hepatitis if an unknown cause has been emerging in hundreds of children worldwide, with the highest numbers in the UK and other parts of Europe. These children presented with acute hepatitis and negative tests for infective, toxic, congenital, or other identifiable causes. A small number of cases progressed to liver failure necessitating transplantation. Molecular testing has revealed a correlation between this hepatitis and human adenovirus, although their specific relationship is still under investigation. The current observational cohort study examined these hepatitis cases at a pediatric liver-transplantation center in the UK. Children presented with jaundice, vomiting, and diarrhea. Human adenovirus was identified in the majority of the patients who underwent testing. Six children developed liver failure requiring transplantation. There were no deaths and all patients were subsequently discharged home. As new cases continue to emerge, this study served as a starting point to identify acute hepatitis of unknown cause in children and provides early evidence of its association with adenovirus.

Click here to read the study in NEJM

In-Depth [retrospective cohort]: This retrospective cohort study involved children referred to one pediatric liver-transplantation center in the UK due to acute hepatitis of unknown cause, between January 1 and April 11, 2022. Patients were screened if they were 16 years of age or younger and had a presentation consistent with the definition of acute hepatitis not due to hepatitis A-E, metabolic, inherited or genetic, congenital or mechanical causes, with serum aminotransferase level >500 IU/L. All children included in this study were 10 years of age or younger. Clinical outcomes were categorized into improvement, liver transplantation, and death. Overall, 44 children were included in this study, all but three were previously healthy. The median age was 4 (range, 1 to 7). The most common presentations prompting medical attention were jaundice (93%), vomiting (54%), diarrhea (32%), abdominal pain (27%), and lethargy (23%). None of the children had been vaccinated against SARS-CoV-2. 11 of the 39 children (28%) who underwent PCR testing tested positive for SARS-CoV-2, while 5 of the 13 children (38%) who underwent SARS-CoV-2 antibody testing tested positive. Most notably, 30 children underwent adenovirus testing, 27 (90%) of whom tested positive. The median adenovirus viral load was also significantly higher in children who needed liver transplantation compared to those who did not. A total of 38 children spontaneously improved while six developed acute liver failure and underwent transplantation. All children were subsequently discharged home. Despite the small cohort size precluding statistical analyses, the study provided early evidence of the association between adenovirus and acute hepatitis of unknown cause in children.

RELATED REPORTS

Higher maternal body mass index is associated with increased risk of cardiovascular disease in offspring

Weight loss is associated with improved vascular function in patients with metabolic dysfunction-associated steatotic liver disease

Melatonin use is associated with lower proportions of rapid eye movement sleep in children

Image: PD

©2022 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent from 2 Minute Medicine, Inc. Inquire about licensing here. No article should be construed as medical advice and is not intended as such by the authors or by 2 Minute Medicine, Inc.

Tags: adenovirusemergencyGastroenterologyhepatitishepatitis of unknown causehepatologyliver failurepediatricpediatrics
Previous Post

Wellness Check: Spirituality

Next Post

Lower glycemic criteria for gestational diabetes did not affect risk of a large-for-gestational-age infant

RelatedReports

Behavioral dysregulation in infancy predicts later child mental health
Cardiology

Higher maternal body mass index is associated with increased risk of cardiovascular disease in offspring

September 12, 2026
Fatty liver disease may independently predict high-risk coronary disease
Cardiology

Weight loss is associated with improved vascular function in patients with metabolic dysfunction-associated steatotic liver disease

August 21, 2026
Parents with poor sleep quality report sleep problems in kids
Pediatrics

Melatonin use is associated with lower proportions of rapid eye movement sleep in children

August 14, 2026
Features predicting treatment failure in acute otitis media
Chronic Disease

Infection risk with infliximab (Remicade) and adalimumab (Humira) is similar in pediatric inflammatory bowel disease

July 14, 2026
Next Post
Impaired brain growth in preterm infants linked with delayed cognitive development

Lower glycemic criteria for gestational diabetes did not affect risk of a large-for-gestational-age infant

No obesity paradox found between BMI, stroke, and death

Remote ischemic conditioning associated with better neurologic function in patients with acute moderate ischemic stroke – the RICAMIS trial

Patients with low back pain or pain at multiple sites at highest risk for chronic opioid use

Reinfection with hepatitis C virus is highest immediately after treatment in patients on opioid agonist therapy

EvidencePulse™ by 2 Minute Medicine 2026 evidence scan 3 reports You asked top stroke trials 2026 Synthesizing medical evidence... Top 2026 stroke trial results: OCEANIC — ischemic stroke: 6.2% vs 8.4% OPTION* — mRS 0–1: 43.6% vs 34.2% ORIENTAL* — mRS 0–2: 58.6% vs 46.6% *Higher sICH in intervention arms Participants randomizedN OCEANIC 12,327 OPTION 570 ORIENTAL 564 Ask about guidelines or landmark trials... ↑ Try EvidencePulse™ Ask the evidence.
Get the signal.
Try it now → Physician-trained medical AI by 2 Minute Medicine

2MM+ All Access

Full details →
$4.99 /month

5-day free trial · cancel anytime

  • ✓100+ physician-written reports
  • ✓EvidencePulse™ + HypeCheck™
  • ✓Ad-free reading + newsletters
Start 5-day free trial

Then $4.99/month. Manage renewal in your account.

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • Higher maternal body mass index is associated with increased risk of cardiovascular disease in offspring
  • Transanastomotic tubes not linked to anastomotic stricture after esophageal atresia repair
  • Artificial intelligence (AI) chatbot reduced depression, anxiety, and eating disorder risk symptoms
License Content
Terms of Use | Disclaimer
Cookie Policy
Cleantalk Pixel
2MM+ All Access Full details →

The medical literature, distilled daily.

Monthly plan selected: $4.99 /month.

$4.99/month

5-day free trial · cancel anytime

Start 5-day free trial

Then $4.99/month. Manage renewal in your account.

Yearly plan selected: $49.90 /year.

$49.90/year

2 months free · only $4.16/month

Start 5-day free trial

Then $49.90/year. Manage renewal in your account.

Membership benefits

  • ✓100+ physician-written reports
  • ✓AI EvidencePulse™ + HypeCheck™
  • ✓Ad-free reading + newsletters

Already a member? Sign in

  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools
    • EvidencePulse™
    • HypeCheck™
    • NPI Registry Lookup
    • RVU Search
  • Pharma
  • AI Roundup
  • The Scan
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • My account
    • Cart
    • Sign-in
No Result
View All Result

© 2026 2 Minute Medicine, Inc. - Physician-written medical news.